Limited
Time Offer: Buy
3 for only $55 |
Cervical
Dysplasia
Lesions
on the cervix cause pain and discomfort for many
women. These lesions, if unattended, can lead
to cervical cancer, the second leading cause of
death for women in the world. Of course, the normal
defenses of the body might cause these lesions
to go away for reasons that are not immediately
apparent. Few want to take that chance, so they
get treatment. The recent work of Dr. Maria C.
Bell1 gives significant hope for the
use of I3CTM, a dietary supplement,
to relieve women with this condition.
What
were Dr. Bells actual results?
Dr.
Bell had 27 subjects, all of which had clinically
observable CIN II-III, treated for 12 weeks
as follows:
a) 10 taking placebo
b) 8 taking 200 mg I3CTM per day
c) 9 taking 400 mg I3CTM per day.
Results: None of the placebo group had complete
regression of CIN, although many had an expected
decrease in severity over the 12 weeks.
Of
the 200 mg per day group, 5 out of 8 had
a reduction and 4 had a complete regression.
Of
the 400-mg per day group all 9 out of 9 had a
reduction in severity and 4 had complete regression.
Cervical
dysplasia is caused by the human papilloma virus
(HPV) of which there are several different strains.
Some HPV strains cause genital warts and some
strains cause laryngeal papillomatosis, also called
recurring respiratory papillomatosis (RRP). The
scientists who study HPV have an International
Papilloma Conference, which meets nearly every
year. In July 2000 the meeting was held in Barcelona,
Spain and about 800 people attended. In 1999 the
meeting was in Charleston, South Carolina. People
attending the HPV conferences are informed about
the relatively aggressive HPV strains 6 and 11
which are most responsible for observable RRP
and about the HPV strain 16 which is most often
responsible for cervical lesions. They know that
HPV-caused CIN I, II, and III, can be precursors
of cervical cancer and prevention of cervical
dysplasia is associated with prevention of cervical
cancer.2 By the way, Dr. Bells
paper was presentedand well receivedin
Barcelona. |